Comparison of the effectiveness of fast-acting insulin aspart with rapid-acting insulin analogues on glycaemic control: a retrospective cohort study using patient data from primary care practices in England

Authors

Usha K Thamattoor
Uffe Christian Braae (ORCID: https://orcid.org/0000-0002-2743-4584)
Pranav Kelkar
Amra Ciric Alibegovic
Rikke Baastrup Nordsborg (ORCID: https://orcid.org/0000-0003-4374-8230)
Anders Boeck Jensen (ORCID: https://orcid.org/0000-0002-5784-308X)
Melanie Jane Davies (ORCID: https://orcid.org/0000-0002-9987-9371)

Institutions

Novo Nordisk (Denmark) (DK)
Leicester General Hospital (GB)
Novo Nordisk (India) (IN)
NIHR Leicester Biomedical Research Centre (GB)

Publication Details

Journal: BMJ Open
Published: 2025-10-01
DOI: https://doi.org/10.1136/bmjopen-2024-093200
Primary Topic: Hyperglycemia and glycemic control in critically ill and hospitalized patients
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Amgen
Eli Lilly and Company
Pfizer
AstraZeneca
Sanofi
Novo Nordisk

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Comparison of the effectiveness of fast-acting insulin aspart with rapid-acting insulin analogues on glycaemic control: a retrospective cohort study using patient data from primary care practices in England

Usha K Thamattoor, Uffe Christian Braae, Pranav Kelkar, Amra Ciric Alibegovic et al.

Oct 1, 2025

BMJ Open

Hyperglycemia and glycemic control in critically ill and hospitalized patients

article

Comparison of the effectiveness of fast-acting insulin aspart with rapid-acting insulin analogues on glycaemic control: a retrospective cohort study using patient data from primary care practices in England

Usha K Thamattoor, Uffe Christian Braae, Pranav Kelkar, Amra Ciric Alibegovic, Rikke Baastrup Nordsborg, Anders Boeck Jensen, Melanie Jane Davies

October 1, 2025article en

Abstract

No abstract available for this paper.

BMJ OpenVol. 15(10)

Novo Nordisk (Denmark) (DK), Leicester General Hospital (GB), Novo Nordisk (India) (IN), NIHR Leicester Biomedical Research Centre (GB)

Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Novo Nordisk

Openalex Percentile: Top 57%

Hyperglycemia and glycemic control in critically ill and hospitalized patients

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.